A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Population

NCT07103148 · clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
2440
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi